Morbidity and Mortality of Intra-aortic Balloon Pumps Placed Through the Aortic Arch

Mueller, Dale K.; Stout, Mark J.; Blakeman, Bradford

doi:10.1378/chest.114.1.85

Cited by 12 publications

(4 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Limitationsmentioning

confidence: 99%

“…Despite this, several case reports and case series have demonstrated this surgical insertion via arch vessels in the clinical setting, and so the positioning of the IABP in this way is not irrelevant to clinical practice. [24][25][26] The other limitation of the MCL study was the occurrence of nonphysiologic retrograde flow in the coronary perfusion experiment. The large peaks (minimal and maximal) demonstrated in this study may have been a result of the limitations of the MCL and may have been caused by a number of reasons including the use of a pinch valve to regulate coronary flow and create biphasic pattern, the inability of the simulated coronary artery to collapse, the lumped-parameter nature of the mock loop, which does not contain compartments for individual vessels, and the extended length of the coronary artery (approximately 1 m), which has higher inertial effects than the native coronary artery.…”

Section: Limitationsmentioning

confidence: 99%

See 1 more Smart Citation

Intra-aortic Balloon Pump Use With Extra Corporeal Membrane Oxygenation—A Mock Circulation Loop Study

et al. 2021

View full text Add to dashboard Cite

Venoarterial extracorporeal membrane oxygenation (ECMO) is used in cardiogenic shock refractory to inotropic support and intra-aortic balloon pump (IABP) support. Peripheral ECMO can lead to ventricular distention, and IABP can be used to mitigate these effects. The aim of this study was to quantify the effects of IABP concomitant with ECMO, under different simulated hemodynamic conditions in a mock circulatory loop. Different simulated states of isolated left ventricular (LV) failure and biventricular failure with graded LV failure severities were supported with ECMO and ECMO with IABP. The impact on left ventricular end-diastolic pressure (LVEDP), volume (LVEDV), coronary flow rate, and cerebral flow rate were evaluated. Left ventricular volumes and pressures increased from the heart failure states with the addition of ECMO. The IABP provided between 3% and 7% reductions in LVEDP and between 1% and 10% reductions in LVEDV. The addition of IABP had minimal effect on cerebral blood flow (0% to 7%), but the variable impact on coronary blood flow with increased diastolic coronary flow of 23% to 50%, but the reduction in mean coronary flow by up to 30%. The efficacy of the IABP was strongly related to ventricular contractility. This study demonstrates the need for careful IABP selection concomitant with ECMO.

show abstract

Section: Limitationsmentioning

confidence: 99%

Section: Limitationsmentioning

confidence: 99%

Intra-aortic Balloon Pump Use With Extra Corporeal Membrane Oxygenation—A Mock Circulation Loop Study

et al. 2021

View full text Add to dashboard Cite

show abstract

“…62,63 When comparing surgical (transthoracic, translumbar, iliac, subclavian, or axillary artery) versus percutaneous approaches, the results are inconclusive with some studies showing improved outcomes with the percutaneous approach while others have suggested decreased adverse events using a surgical approach. 64-67 The limb with the strongest pulse and largest artery should be utilized. Optimal positioning is confirmed with imaging with the balloon tip in the descending thoracic aorta, 2 to 3 cm distal to the subclavian artery (Figure 1).…”

Section: Insertion Of Intra-aortic Balloon Pumpsmentioning

confidence: 99%

Management of Intra-Aortic Balloon Pumps

Webb

Weyker

Flynn

2014

Semin Cardiothorac Vasc Anesth

View full text Add to dashboard Cite

Intra-aortic balloon pumps (IABPs) continue to be the most widely used cardiac support devices with an annual estimate of 200 000 IABPs placed worldwide. IABPs enhance myocardial function by maximizing oxygen supply and minimizing oxygen demand. The use of IABPs is not without risk, with major vascular injury, ischemia, and infection being the most common complications, especially in high-risk patients. While recent studies have questioned the use of IABPs in patients with cardiogenic shock secondary to myocardial infarction, these studies have limitations making it difficult to formulate definitive conclusions. This review will focus on the mechanisms of counterpulsation, the management of IABPs and the evidence supporting this ventricular support therapy.

show abstract

“…Other techniques, including artery exposure (dissection), have been appointed as predictors of further complications, such as dissection and rupture of the aorta, intense hemorrhages and patient death (8)(9) .…”

Section: Iabp-related Complicationsmentioning

confidence: 99%

Complications of intra-aortic balloon in a cohort of hospitalized patients: implications for nursing care

Assis¹,

Azzolin

Boaz

et al. 2009

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

show abstract

Morbidity and Mortality of Intra-aortic Balloon Pumps Placed Through the Aortic Arch

Cited by 12 publications

References 19 publications

Intra-aortic Balloon Pump Use With Extra Corporeal Membrane Oxygenation—A Mock Circulation Loop Study

Intra-aortic Balloon Pump Use With Extra Corporeal Membrane Oxygenation—A Mock Circulation Loop Study

Management of Intra-Aortic Balloon Pumps

Complications of intra-aortic balloon in a cohort of hospitalized patients: implications for nursing care

Contact Info

Product

Resources

About